Article
Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience.
Histopathology - 1 Jun 2024
Moysset Irene, Castrejon Natalia, Garcia-Herrera Adriana, Castillo Paola, Marginet Marta, Teixido Cristina, Podlipnik Sebastian, Albero-Gonzalez Raquel, Montironi Carla, Navarro Judit, Rovira Carlota, Puig Susana, Carrera Cristina, Alos Llucia
Abstract excerpt
AIMS: The current WHO classification of melanocytic tumours excludes neoplasms showing BRAF or NRAS mutations from the Spitz category. This study aimed to review and reclassify atypical melanocytic tumours with spitzoid morphological features diagnosed between 2009 and 2021 in our hospital after expanding the molecular profile, including BRAF and NRAS mutations in all cases. METHODS AND RESULTS: A total of 71...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.